1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,020 | 2,100 | 26.07. | |
| 2,020 | 2,100 | 26.07. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | COVID is Here to Stay and NV-387 is a Much Needed Drug Against It, Reminds NanoViricides | 327 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / July 24, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today reminds the strong... ► Artikel lesen | |
| 11.07. | A Single Drug Against Multiple Respiratory Virus Infections - COVID, RSV, Influenza, Bird Flu - Planning Next Phase of Clinical Trials, Says NanoViricides | 495 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / July 11, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader in broad-spectrum antiviral nanomedicines, discusses its development... ► Artikel lesen | |
| 24.06. | NanoViricides, Inc.: A Novel Broad-Spectrum Antiviral Against Influenza A Viruses, NV-387, Could Be an Important Weapon to Fight Bird Flu H5N1, Says NanoViricides | 487 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / June 24, 2024 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), a clinical stage global leader in broad-spectrum antiviral nanomedicines, comments that the ultra-broad-spectrum... ► Artikel lesen | |
| 20.06. | NanoViricides, Inc.: A Novel Broad-Spectrum Antiviral Against Influenza A Viruses, NV-387, Is Effective in Protecting Lungs from Damage in Lethally Infected Animal Model | 505 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / June 20, 2024 / NanoViricides, Inc. (NYSE AmerIcan.:NNVC) (the "Company"), a clinical stage company and global leader in broad-spectrum antiviral nanomedicines, reports that... ► Artikel lesen | |
| 11.06. | NanoViricides, Inc.: Orally Administered NV-387 Results in Ideal Flat Blood Concentration Profile for Sustained Antiviral Effect | 476 | ACCESSWIRE | A First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral Infections Including RSV, COVID, Influenzas and More SHELTON, CT / ACCESSWIRE / June 11, 2024 / NanoViricides... ► Artikel lesen | |
| 04.06. | NanoViricides, Inc.: The Sustained, Slow Declining, Blood Concentration Profile of NV-387 Enables Infrequent Dosing for Strong Antiviral Effect | 471 | ACCESSWIRE | A First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral Infections Including RSV, COVID, Influenzas and More SHELTON, CT / ACCESSWIRE / June 4, 2024 / NanoViricides... ► Artikel lesen | |
| 29.05. | SMLR, NNVC and QBTS are among premarket gainers | 40 | Seeking Alpha | ||
| 29.05. | NanoViricides, Inc.: A First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral Infections Including RSV, COVID, Influenzas and More | 507 | ACCESSWIRE | Novel Host-Mimetic, Virus Killing Technology Platform SHELTON, CT / ACCESSWIRE / May 29, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical-stage global leader in broad-spectrum... ► Artikel lesen | |
| 23.05. | NanoViricides, Inc.: NanoViricides Bolsters Partnership Efforts - Engages Aagami Inc. | 528 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / May 23, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical-stage global leader in broad-spectrum antiviral nanomedicines, reports that it has engaged... ► Artikel lesen | |
| 20.05. | NanoViricides, Inc.: Lethally RSV Infected Animals Orally Treated with NV-387 Showed Normal Lung Histology, Indicating Potential Cure | 687 | ACCESSWIRE | NV-387, A Broad-Spectrum Antiviral with Strong Activity Against RSV, Influenza A, Coronaviruses, Others SHELTON, CT / ACCESSWIRE / May 20, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company")... ► Artikel lesen | |
| 15.05. | NanoViricides GAAP EPS of -$0.16 | 2 | Seeking Alpha | ||
| 15.05. | NanoViricides, Inc.: NanoViricides Has Filed its Quarterly Report | 810 | ACCESSWIRE | NV-387 Advancing to Phase II Clinical Trial for the Treatment of RSV Infection SHELTON, CT / ACCESSWIRE / May 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in... ► Artikel lesen | |
| 14.05. | NanoViricides, Inc.: A Novel Broad-Spectrum Antiviral with Activity Against RSV | 406 | ACCESSWIRE | Complete Survival of Animals Lethally Infected into Lungs with RSV Achieved Upon NV-387 Oral Treatment SHELTON, CT / ACCESSWIRE / May 14, 2024 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company")... ► Artikel lesen | |
| 10.05. | NanoViricides, Inc.: NanoViricides to Participate in the 2024 EF Hutton Annual Global Conference On May 15 in New York City | 549 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / May 10, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan, Ph.D.... ► Artikel lesen | |
| 08.05. | NanoViricides, Inc.: A Novel Broad-Spectrum Antiviral with Activity Against Smallpox/Mpox | 482 | ACCESSWIRE | NV-387 Possesses Strong Orthopoxvirus Activity Relevant to Both Sexual and Inhalation Modes of Transmission, Says NanoViricides SHELTON, CT / ACCESSWIRE / May 8, 2024 / NanoViricides, Inc. (NYSE American:NNVC)... ► Artikel lesen | |
| 07.05. | NanoViricides, TC BioPharm, Holdco Nuvo among healthcare movers | 11 | Seeking Alpha | ||
| 06.05. | NanoViricides, Outset Medical, EyePoint Pharmaceuticals among healthcare movers | 6 | Seeking Alpha | ||
| 06.05. | NanoViricides, Inc.: A Novel Broad-Spectrum Antiviral with Activity Against Influenza A | 808 | ACCESSWIRE | NV-387 Possesses Strong Anti-Influenza-A Virus Activity, and May Have Activity Against H5N1 Bird Flu Virus, Says NanoViricides SHELTON, CT / ACCESSWIRE / May 6, 2024 / NanoViricides, Inc. (NYSE American:NNVC)... ► Artikel lesen | |
| 30.04. | NanoViricides, Inc.: NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon | 764 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / April 30, 2024 / NanoViricides, Inc. (NYSE Amer:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, reports that the Phase I Clinical Trial of... ► Artikel lesen | |
| 05.04. | NANOVIRICIDES, INC. - 8-K, Current Report | 2 | SEC Filings |
Seite:
1 2 Weiter >>
34 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 51,90 | +5,06 % | EQS-Adhoc: Formycon AG: Stelara® Biosimilar-Kandidat FYB202 (Ustekinumab) erhält CHMP-Empfehlung der EMA | EQS-Ad-hoc: Formycon AG / Schlagwort(e): Stellungnahme/Zulassungsantrag
Stelara® Biosimilar-Kandidat FYB202 (Ustekinumab) erhält CHMP-Empfehlung der EMA
26.07.2024 / 10:54 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| GAUZY | 10,380 | +8,01 % | Gauzy Ltd. Announces Preliminary Revenue Ranges, Demonstrating Strong Double-Digit Growth for the Second Quarter and First Half 2024 that Exceeded Expectations | TEL AVIV, Israel, July 15, 2024 (GLOBE NEWSWIRE) -- Gauzy Ltd. (Nasdaq: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control solutions, today provided preliminary unaudited... ► Artikel lesen | |
| ACACIA RESEARCH | 5,250 | +7,14 % | Acacia Research Reports First Quarter 2024 Financial Results | NEW YORK--(BUSINESS WIRE)--Acacia Research Corporation (Nasdaq: ACTG) ("Acacia" or the "Company") today reported financial results for the three months ended March 31, 2024.
Martin ("MJ") D.... ► Artikel lesen | |
| NVE | 77,00 | -1,91 % | Dividendenbekanntmachungen (10.05.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AAK AB SE0011337708 3,7 SEK 0,3163 EUR ADDLIFE AB SE0014401378 0,5 SEK 0,0427 EUR ALEXANDERS INC US0147521092 4,5 USD 4,1738... ► Artikel lesen | |
| KOPIN | 1,009 | +1,92 % | Kopin Corporation: Kopin Expands Medical Offerings to Include Spatial Light Modulator That Enable Super-Resolution Microscopes | Ferroelectric LCOS modulators advance open-source research at top Medical, Biomedical and Research Institutions
Kopin Corporation (NASDAQ: KOPN), a leader in cutting-edge high-performance application-specific... ► Artikel lesen | |
| FENDX TECHNOLOGIES | 0,158 | -2,48 % | FendX Technologies Inc.: FendX Completes Successful Pilot Scale-Up Run of REPELWRAP Film with Dunmore | Oakville, Ontario--(Newsfile Corp. - July 24, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX") a nanotechnology company developing surface protection... ► Artikel lesen | |
| VEECO INSTRUMENTS | 36,000 | -1,10 % | Veeco Instruments Inc.: Veeco Reports Fourth Quarter and Fiscal Year 2023 Financial Results | Fourth Quarter 2023 Highlights: Revenue of $173.9 million, compared with $153.8 million in the same period last yearGAAP net income of $21.6 million, or $0.37 per diluted share, compared with $128.9... ► Artikel lesen | |
| XTPL | 24,350 | -5,07 % | EQS-News: XTPL S.A.: XTPL achieves PLN 5.5 million of commercial sales in H1 2024, two industrial modules delivered to clients | Issuer: XTPL S.A.
/ Key word(s): Preliminary Results/Sales Result
XTPL achieves PLN 5.5 million of commercial sales in H1 2024, two industrial modules delivered to clients
18.07.2024... ► Artikel lesen | |
| ONTO INNOVATION | 177,00 | +1,72 % | (ONTO) - Analyzing Onto Innovation's Short Interest | ||
| ADVANCE ZINCTEK | 0,432 | -1,82 % | ADVANCE ZINCTEK LIMITED: FY24 Loss Before Tax | ||
| NANOFOCUS | 1,250 | 0,00 % | EQS-Adhoc: NanoFocus AG: Ergänzungsverlangen zur Tagesordnung der ordentlichen Hauptversammlung am 28. August 2024 | EQS-Ad-hoc: NanoFocus AG / Schlagwort(e): Hauptversammlung
NanoFocus AG: Ergänzungsverlangen zur Tagesordnung der ordentlichen Hauptversammlung am 28. August 2024
25.07.2024 / 19:27 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| LEHNER INVESTMENTS | 0,013 | 0,00 % | EQS-DD: LEHNER INVESTMENTS AG: RIMIVY LTD, Verkauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
05.07.2024 / 16:36... ► Artikel lesen | |
| RIBER | 2,470 | 0,00 % | Riber's first-half revenue up 13% year-on-year to €13.7m | ||
| ZENTEK | 0,875 | -6,42 % | Zentek Launches National Sampling Program for ZenGUARD Antimicrobial Surgical Masks | GUELPH, ON / ACCESSWIRE / July 24, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company announces that it will embark... ► Artikel lesen | |
| GOMSPACE | 0,429 | -1,15 % | GOMSPACE A/S: GomSpace issues a market update highlighting a positive free cashflow in Q2 and a strong improvement on order backlog |
NANOVIRICIDES INC gehört der Branche Nanotechnologie an. Mit einer aktuellen Kursveränderung von +0,020 (+0,97 %) liegt der Kurs bei 2,080 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NANOVIRICIDES INC finden Sie auf Wallstreet Online.
